Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Sokolova, Ekaterina Alekseevna ^a   Malkova, Nadezhda Alekseevna ^b   Korobko, Denis Sergeevich ^b   Rozhdestvenskii, Aleksey Sergeevich ^c   Kakulya, Anastasia Vladimirovna ^d   Khanokh, Elena Vladimirovna ^e   Delov, Roman Andreevich ^c   Platonov, Fedor Alekseevich ^f   Popova, Tatyana Yegorovna ^g   Arefeva, Elena Gennadievna ^h   Zagorskaya, Natalia Nikolaevna ^h   Alifirova, Valentina Mikhailovna ⁱ   Titova, Marina Andreevna ⁱ   Smagina, Inna Vadimovna ^j,k   Elchaninova, Svetlana Alksandrovna ^k   Popovtseva, Anna Valentinovna ^k   Puzyrev, Valery Pavlovich ^l   Kulakova, Olga Georgievna ^m   Tsareva, Ekaterina Yur'evna ^m   Favorova, Olga Olegovna ^m   Shchur, Sergei Gennadievich ^m,n   Lashch, Natalia Yurievna ^m,n   Popova, Natalia Fyodorovna ^m,n   Popova, Ekaterina Valerievna ^m,n   Gusev, Evgenii Ivanovich ^m,n   Boyko, Aleksey Nikolaevich ^m,n   Aulchenko, Yurii Sergeevich ^a,o   Filipenko, Maxim Leonidovich ^a   more..

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b State Novosibirsk Regional Clinical Hospital   (Russian Federation)

^c Omsk State Engineering University   (Russian Federation)

^d Omsk Regional Narcology Clinic   (Russian Federation)

^e Clinical Diagnostic Center   (Russian Federation)

^f Multiple Sclerosis Center   (Russian Federation)

^g NORTH EASTERN FEDERAL UNIVERSITY   (Russian Federation)

^h State Budgetary Healthcare Institution Kemerovo Regional Clinical Hospital   (Russian Federation)

ⁱ SIBERIAN STATE MEDICAL UNIVERSITY   (Russian Federation)

^j Territorial Clinical Hospital   (Russian Federation)

^k ALTAI STATE MEDICAL UNIVERSITY   (Russian Federation)

^l RESEARCH INSTITUTE OF MEDICAL GENETICS   (Russian Federation)

^m PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

ⁿ The 11th City Hospital of Moscow   (Russian Federation)

^o INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ADULT; ARTICLE; CD40 GENE; CHROMOSOME 20Q; CHROMOSOME 20Q13; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; RUSSIAN; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; GENETICS; HAPLOTYPE; RUSSIAN FEDERATION; STATISTICAL MODEL;

ADULT; ALLELES; ANTIGENS, CD40; FEMALE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RUSSIA;

EID: 84876442642     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061032     Document Type: Article

References (37)

1. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, et al. (2009) Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Human molecular genetics 18: 767-778.
2. De Jager PL, Jia X, Wang J, De Bakker PIW, Ottoboni L, et al. (2009) Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nature genetics 41: 776-782.
3. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, et al. (2007) Risk alleles for multiple sclerosis identified by a genomewide study. The New England journal of medicine 357: 851-862.
4. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, et al. (2008) Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nature genetics 40: 1402-1403.
5. Comabella M, Craig DW, Camiña-Tato M, Morcillo C, Lopez C, et al. (2008) Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PloS one 3: e3490.
6. Jakkula E, Leppä V, Sulonen A-M, Varilo T, Kallio S, et al. (2010) Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. American journal of human genetics 86: 285-291.
7. The Australia and New Zealand Multiple Sclerosis Genetics Consortium (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nature genetics 41: 824-828.
8. Matesanz F, González-Pérez A, Lucas M, Sanna S, Gayán J, et al. (2012) Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PloS one 7: e36140.
9. Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, et al. (2012) A genome-wide association study in progressive multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England) 18: 1384-1394.
10. Sanna S, Pitzalis M, Zoledziewska M, Zara I, Sidore C, et al. (2010) Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nature genetics 42: 495-497.
11. Diekstra FP, Saris CGJ, Van Rheenen W, Franke L, Jansen RC, et al. (2012) Mapping of gene expression reveals CYP27A1 as a susceptibility gene for sporadic ALS. PloS one 7: e35333.
12. Nischwitz S, Cepok S, Kroner A, Wolf C, Knop M, et al. (2010) Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of neuroimmunology 227: 162-166.
13. Briggs FB, Shao X, Goldstein BA, Oksenberg JR, Barcellos LF DJP, (2011) Genome-wide association study of severity in multiple sclerosis. Genes and immunity 12: 615-625.
14. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, et al. (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nature genetics 39: 1329-1337.
15. Sawcer S, Hellenthal G, Pirinen M, Spencer CCa, Patsopoulos Na, et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
16. Vazgiourakis VM, Zervou MI, Choulaki C, Bertsias G, Melissourgaki M, et al. (2011) A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis. Annals of the rheumatic diseases 70: 2184-2190.
17. Orozco G, Eyre S, Hinks A, Ke X, Wilson AG, et al. (2010) Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study. Annals of the rheumatic diseases 69: 813-816.
18. Blanco-Kelly F, Matesanz F, Alcina A, Teruel M, Díaz-Gallo LM, et al. (2010) CD40: novel association with Crohn's disease and replication in multiple sclerosis susceptibility. PloS one 5: e11520.
19. Jacobson EM, Concepcion E, Oashi T, Tomer Y, (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146: 2684-2691.
20. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, et al. (1997) CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. Journal of immunology (Baltimore, Md/: 1950) 159: 4620-4627.
21. Grammer AC, Slota R, Fischer R, Gur H, Girschick H, et al. (2003) Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions. The Journal of clinical investigation 112: 1506-1520.
22. Durie FH, Fava RA, Foy TM, Aruffo A, Ledbetter JA, et al. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (New York, NY) 261: 1328-1330.
23. Kyburz D, Carson DA, Corr M, (2000) The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis. Arthritis and rheumatism 43: 2571-2577.
24. Barbé-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, et al. (2006) CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes 55: 2437-2445.
25. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, et al. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 93: 2499-2504.
26. Denfeld RW, Hollenbaugh D, Fehrenbach A, Weiss JM, Von Leoprechting A, et al. (1996) CD40 is functionally expressed on human keratinocytes. European journal of immunology 26: 2329-2334.
27. Toubi E, Shoenfeld Y, (2004) The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 37: 457-464.
28. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of neurology 50: 121-127.
29. Skibola CF, Nieters A, Bracci PM, Curry JD, Agana L, et al. (2008) A functional TNFRSF5 gene variant is associated with risk of lymphoma. Blood 111: 4348-4354.
30. Nieters A, Bracci PM, De Sanjosé S, Becker N, Maynadié M, et al. (2011) A functional TNFRSF5 polymorphism and risk of non-Hodgkin lymphoma, a pooled analysis. International journal of cancer Journal international du cancer 128: 1481-1485.
31. Pineda B, Tarín JJ, Hermenegildo C, Laporta P, Cano A, et al. (2011) Gene-gene interaction between CD40 and CD40L reduces bone mineral density and increases osteoporosis risk in women. Osteoporosis international/: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 22: 1451-1458.
32. Shuang C, Dalin L, Weiguang Y, Zhenkun F, Fengyan X, et al. (2011) Association of CD40 gene polymorphisms with sporadic breast cancer in Chinese Han women of Northeast China. PloS one 6: e23762.
33. Chen F, Hou S, Jiang Z, Chen Y, Kijlstra A, et al. (2012) CD40 gene polymorphisms confer risk of Behcet's disease but not of Vogt-Koyanagi-Harada syndrome in a Han Chinese population. Rheumatology (Oxford, England) 51: 47-51.
34. Liu R, Xu N, Wang X, Shen L, Zhao G, et al. (2012) Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Molecular biology reports 39: 6915-6922.
35. Peters AL, Plenge RM, Graham RR, Altshuler DM, Moser KL, et al. (2008) A novel polymorphism of the human CD40 receptor with enhanced function. Blood 112: 1863-1871.
36. MacDonald AS, Straw AD, Dalton NM, Pearce EJ, (2002) Cutting edge: Th2 response induction by dendritic cells: a role for CD40. Journal of immunology (Baltimore, Md/: 1950) 168: 537-540.
37. Patsopoulos NA, Esposito F, Reischl J, Lehr S, Bauer D, et al. (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Annals of neurology 70: 897-912.